|
FY2021
12 months to Dec 31, 2021
|
FY2020
5 months to Dec 31, 2020
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Interest earned on investment held in Trust Account | ||
| Change in fair value of warrant liabilities | ||
| Offering costs attributable to warrant liability | ||
| Changes in assets and liabilities: | ||
| Increase in prepaid expenses | ||
| Increase in accounts payable | ||
| Increase in accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash in Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from notes payable-related party | ||
| Proceeds from issuance of common stock to sponsor | ||
| Class A | ||
| Class B | ||
| Total proceeds from issuance of common stock to sponsor | ||
| Pay-off of notes payable-related party | ||
| Payments of offering costs associated with initial public offering | ||
| Net cash provided by financing activities | ||
| Net increase in cash | ||
| Cash, beginning of period | ||
| Cash, end of period | ||
| Supplemental disclosure of noncash operating and financing activities: | ||
| Initial classification of warrant liability | ||
| Deferred underwriting fee payable | ||
| Offering costs included in accounts payable and accrued expenses |
Loading...
